Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

2.
3.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
4.

CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.

Saad RS, Silverman JF, Khalifa MA, Rowsell C.

Appl Immunohistochem Mol Morphol. 2009 May;17(3):196-201. doi: 10.1097/PAI.0b013e31819268f2. Erratum in: Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):464.

PMID:
19098678
5.
6.

Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.

Bayrak R, Yenidünya S, Haltas H.

Pathol Res Pract. 2011 Mar 15;207(3):156-60. doi: 10.1016/j.prp.2010.12.005. Epub 2011 Feb 1.

PMID:
21282015
9.

Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.

Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Antón I.

Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):142-6.

PMID:
15894926
10.
11.

Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.

Gurzu S, Jung I.

Pathol Res Pract. 2012 Mar 15;208(3):163-6. doi: 10.1016/j.prp.2012.01.003. Epub 2012 Feb 21.

PMID:
22361037
12.

Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Vang R, Gown AM, Wu LS, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.

Mod Pathol. 2006 Nov;19(11):1421-8. Epub 2006 Sep 15.

13.

[CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].

Yue C, Piao Y, Bai Y, Liu H, Zhang L.

Zhonghua Yi Xue Za Zhi. 2015 Aug 11;95(30):2447-50. Chinese.

PMID:
26711206
14.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18.

15.

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.

Lugli A, Tzankov A, Zlobec I, Terracciano LM.

Mod Pathol. 2008 Nov;21(11):1403-12. doi: 10.1038/modpathol.2008.117. Epub 2008 Jun 27.

16.
17.

Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.

Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, Penninckx F, Geboes K, Ectors N.

Mod Pathol. 2004 Jan;17(1):49-55.

20.

Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.

Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.

Am J Surg Pathol. 2006 Sep;30(9):1130-9.

PMID:
16931958
Items per page

Supplemental Content

Write to the Help Desk